108 related articles for article (PubMed ID: 1560675)
41. [The cellular and molecular-biological studies on Philadelphia chromosome-positive acute lymphocytic leukemia].
Kunieda Y
Hokkaido Igaku Zasshi; 1993 May; 68(3):337-49. PubMed ID: 8319933
[TBL] [Abstract][Full Text] [Related]
42. The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia.
Bacher U; Schnittger S; Kern W; Hiddemann W; Haferlach T; Schoch C
Haematologica; 2005 Apr; 90(4):558-9. PubMed ID: 15820957
[TBL] [Abstract][Full Text] [Related]
43. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
44. [Amplification and rearrangement of proto-oncogene c-abl in human leukemia cells].
Jin XM; Miao J; Xu Y; Deng GR
Zhonghua Zhong Liu Za Zhi; 1988 May; 10(3):167-70. PubMed ID: 3219975
[TBL] [Abstract][Full Text] [Related]
45. Treatment of chronic myelogenous leukemia (CML) with c-myb antisense oligodeoxynucleotides.
Gewirtz AM
Bone Marrow Transplant; 1994; 14 Suppl 3():S57-61. PubMed ID: 7697011
[No Abstract] [Full Text] [Related]
46. Clinical significance of BCR-ABL fusion gene subtypes in chronic myelogenous and acute lymphoblastic leukemias.
Ye YX; Zhou J; Zhou YH; Zhou Y; Song XB; Wang J; Lin L; Ying BW; Lu XJ
Asian Pac J Cancer Prev; 2014; 15(22):9961-6. PubMed ID: 25520136
[TBL] [Abstract][Full Text] [Related]
47. BCR/ABL mRNA targeting small interfering RNA effects on proliferation and apoptosis in chronic myeloid leukemia.
Zhu XS; Lin ZY; Du J; Cao GX; Liu G
Asian Pac J Cancer Prev; 2014; 15(12):4773-80. PubMed ID: 24998540
[TBL] [Abstract][Full Text] [Related]
48. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
49. Further evidence of the involvement of the c-abl oncogene in chronic myelogenous leukemia and acute lymphocytic leukemia.
Szabo P; Macera MJ; Verma RS
Mol Biol Med; 1988 Dec; 5(3):139-44. PubMed ID: 3072467
[TBL] [Abstract][Full Text] [Related]
50. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
51. A comparative analysis of cytoplasmic mu (C mu) expression in acute lymphoblastic leukemia by molecular and immunologic techniques. Identification of leukemia cases expressing C mu mRNA transcripts in the absence of detectable C mu proteins.
Little JV; Foucar K; Duncan MH; Crago SS; McConnell TS; Griffith B; Chen IM; Vogler LB; Willman CL
Am J Clin Pathol; 1992 Jun; 97(6):885-92. PubMed ID: 1595611
[TBL] [Abstract][Full Text] [Related]
52. Characteristic patterns of HOX gene expression in different types of human leukemia.
Celetti A; Barba P; Cillo C; Rotoli B; Boncinelli E; Magli MC
Int J Cancer; 1993 Jan; 53(2):237-44. PubMed ID: 7678830
[TBL] [Abstract][Full Text] [Related]
53. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.
Ratajczak MZ; Kant JA; Luger SM; Hijiya N; Zhang J; Zon G; Gewirtz AM
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11823-7. PubMed ID: 1281545
[TBL] [Abstract][Full Text] [Related]
54. [Expression of CIAPIN1 gene in BMMNC of patients with leukemia].
Li B; Li QH; Lin YN; Jin WN; Pang TX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):570-3. PubMed ID: 21729524
[TBL] [Abstract][Full Text] [Related]
55. [Expression of c-fes gene in leukemia cells and its clinical significance].
Zhang YL; Ren JH; Guo XN; Zhang JN; Wang Y; Qiao SK; Lin FR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1429-33. PubMed ID: 20030920
[TBL] [Abstract][Full Text] [Related]
56. A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia.
van Stijn A; Kok A; van der Pol MA; Feller N; Roemen GM; Westra AH; Ossenkoppele GJ; Schuurhuis GJ
Leukemia; 2003 Apr; 17(4):780-6. PubMed ID: 12682637
[TBL] [Abstract][Full Text] [Related]
57. MicroRNAs: the primary cause or a determinant of progression in leukemia?
Bousquet M; Lodish HF
Expert Rev Hematol; 2011 Apr; 4(2):121-3. PubMed ID: 21495919
[No Abstract] [Full Text] [Related]
58. Two color flow cytometric analysis of concomitant acute myeloid leukemia and chronic lymphocytic leukemia.
Tamul KR; Meyers DC; Bentley SA; Folds JD
Cytometry; 1994 Mar; 18(1):30-4. PubMed ID: 7521818
[TBL] [Abstract][Full Text] [Related]
59. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
60. The study of AgNOR proteins in leukemias: diagnostic value and correlation to S-phase cell fraction.
Klobusická M; Babusíková O; Mesárosová A; Kusenda J; Glasová M
Neoplasma; 1996; 43(6):397-401. PubMed ID: 8996564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
